Publications

Found 25 results
Filters: Author is Benoît Stijlemans  [Clear All Filters]
2015
Zheng, F., N. Devoogdt, A. Sparkes, Y. Morias, C. Abels, B. Stijlemans, T. Lahoutte, S. Muyldermans, P. De Baetselier, S. Schoonooghe, et al., "Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm.", Immunobiology, vol. 220, issue 2, pp. 200-9, 2015 Feb.
2014
La Greca, F., C. Haynes, B. Stijlemans, C. De Trez, and S. Magez, "Antibody-mediated control of Trypanosoma vivax infection fails in the absence of tumour necrosis factor.", Parasite Immunol, vol. 36, issue 6, pp. 271-6, 2014 Jun.
2012
Caljon, G., K. De Ridder, B. Stijlemans, M. Coosemans, S. Magez, P. De Baetselier, and J. Van Den Abbeele, "Tsetse salivary gland proteins 1 and 2 are high affinity nucleic acid binding proteins with residual nuclease activity.", PLoS One, vol. 7, issue 10, pp. e47233, 2012.
Caljon, G., V. Caveliers, T. Lahoutte, B. Stijlemans, G. H. Ghassabeh, J. Van Den Abbeele, I. Smolders, P. De Baetselier, Y. Michotte, S. Muyldermans, et al., "Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.", Br J Pharmacol, vol. 165, issue 7, pp. 2341-53, 2012 Apr.
2011
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
2010
Stijlemans, B., A. Vankrunkelsven, G. Caljon, V. Bockstal, M. Guilliams, T. Bosschaerts, A. Beschin, G. Raes, S. Magez, and P. De Baetselier, "The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches.", Endocr Metab Immune Disord Drug Targets, vol. 10, issue 1, pp. 71-82, 2010 Mar.
Magez, S., G. Caljon, T. Tran, B. Stijlemans, and M. Radwanska, "Current status of vaccination against African trypanosomiasis.", Parasitology, vol. 137, issue 14, pp. 2017-27, 2010 Dec.
Stijlemans, B., A. Vankrunkelsven, L. Brys, G. Raes, S. Magez, and P. De Baetselier, "Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis.", Microbes Infect, vol. 12, issue 5, pp. 389-99, 2010 May.
2009
Muyldermans, S., T. Nath Baral, C. V Retamozzo, P. De Baetselier, E. De Genst, J. Kinne, H. Leonhardt, S. Magez, V. K. Nguyen, H. Revets, et al., "Camelid immunoglobulins and nanobody technology.", Vet Immunol Immunopathol, vol. 128, issue 1-3, pp. 178-83, 2009 Mar 15.
2008
Saerens, D., B. Stijlemans, T. Nath Baral, G. Thanh Nguy Thi, U. Wernery, S. Magez, P. De Baetselier, S. Muyldermans, and K. Conrath, "Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.", J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
Stijlemans, B., A. Vankrunkelsven, L. Brys, S. Magez, and P. De Baetselier, "Role of iron homeostasis in trypanosomiasis-associated anemia.", Immunobiology, vol. 213, issue 9-10, pp. 823-35, 2008.
2007
Stijlemans, B., M. Guilliams, G. Raes, A. Beschin, S. Magez, and P. De Baetselier, "African trypanosomosis: from immune escape and immunopathology to immune intervention.", Vet Parasitol, vol. 148, issue 1, pp. 3-13, 2007 Aug 19.
Stijlemans, B., T. Nath Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez, "A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology.", J Immunol, vol. 179, issue 6, pp. 4003-14, 2007 Sep 15.
2006
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].", Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.", Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
Caljon, G., J. Van Den Abbeele, B. Stijlemans, M. Coosemans, P. De Baetselier, and S. Magez, "Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.", Infect Immun, vol. 74, issue 11, pp. 6324-30, 2006 Nov.
2005
Conrath, K., C. Vincke, B. Stijlemans, J. Schymkowitz, K. Decanniere, L. Wyns, S. Muyldermans, and R. Loris, "Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.", J Mol Biol, vol. 350, issue 1, pp. 112-25, 2005 Jul 1.
Drennan, M. B., B. Stijlemans, J. Van Den Abbeele, V. J. Quesniaux, M. Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, and S. Magez, "The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.", J Immunol, vol. 175, issue 4, pp. 2501-9, 2005 Aug 15.
2004
Stijlemans, B., K. Conrath, V. Cortez-Retamozo, H. Van Xong, L. Wyns, P. Senter, H. Revets, P. De Baetselier, S. Muyldermans, and S. Magez, "Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.", J Biol Chem, vol. 279, issue 2, pp. 1256-61, 2004 Jan 9.
Magez, S., C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P. Brouckaert, F. Brombacher, E. Pays, and P. De Baetselier, "P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis.", J Infect Dis, vol. 189, issue 3, pp. 527-39, 2004 Feb 1.
2002
Magez, S., B. Stijlemans, G. Caljon, H-P. Eugster, and P. De Baetselier, "Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.", Infect Immun, vol. 70, issue 3, pp. 1342-51, 2002 Mar.
Magez, S., B. Stijlemans, T. Nath Baral, and P. De Baetselier, "VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology.", Microbes Infect, vol. 4, issue 9, pp. 999-1006, 2002 Jul.
2001
Magez, S., M. Radwanska, B. Stijlemans, H. V. Xong, E. Pays, and P. De Baetselier, "A conserved flagellar pocket exposed high mannose moiety is used by African trypanosomes as a host cytokine binding molecule.", J Biol Chem, vol. 276, issue 36, pp. 33458-64, 2001 Sep 7.
2000
Radwanska, M., S. Magez, A. Michel, B. Stijlemans, M. Geuskens, and E. Pays, "Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.", Infect Immun, vol. 68, issue 2, pp. 848-60, 2000 Feb.
1998
Magez, S., B. Stijlemans, M. Radwanska, E. Pays, M. A. Ferguson, and P. De Baetselier, "The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors.", J Immunol, vol. 160, issue 4, pp. 1949-56, 1998 Feb 15.